electroCore Inc. (NASDAQ: ECOR)
$6.33
+0.0451 ( +0.72% ) 2.8K
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Market Data
Open
$6.33
Previous close
$6.28
Volume
2.8K
Market cap
$40.60M
Day range
$6.09 - $6.30
52 week range
$3.92 - $8.08
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 08, 2023 |
4 | Insider transactions | 1 | Aug 08, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
4 | Insider transactions | 1 | Aug 03, 2023 |
4 | Insider transactions | 1 | Aug 02, 2023 |
8-k | 8K-related | 19 | Jul 31, 2023 |